DY
ACH

Dowling & Yahnke’s Accendra Health ACH Stock Holding History

Dowling & Yahnke’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,235
Closed -$382K – 273
2014
Q2 		$382K Hold
11,235
– – 0.05% 216
2014
Q1 		$394K Buy
+11,235
New +$396K 0.05% 209

Other funds holding ACH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Dowling & Yahnke's ACH Position: Q3 2014 in Review

Dowling & Yahnke sold out of Accendra Health (ACH) in Q3 2014, closing a stake of 11,235 shares — an estimated $382K sold.

Dowling & Yahnke first reported a position in ACH in Q1 2014 and held it in 2 quarters. The position peaked at $394K in Q1 2014. 224 funds tracked by Wall St. Rank hold ACH as of Q3 2014.

  • Dowling & Yahnke reported no remaining Accendra Health position as of Q3 2014 after selling out during the quarter.
  • Dowling & Yahnke sold 11,235 Accendra Health shares in Q3 2014, an estimated $382K.
  • Dowling & Yahnke first reported a position in Accendra Health in Q1 2014 and held it in 2 quarters.
  • Dowling & Yahnke's Accendra Health position peaked at $394K in Q1 2014.
  • 224 funds tracked by Wall St. Rank held Accendra Health as of Q3 2014.

Based on Dowling & Yahnke's 13F filing for Q3 2014, filed 22 Oct 2014.